logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – DPYD genotyping before fluoropyrimidine-based therapy: time for action

Adjusting dose by genotype reduces toxicity and should be standard of care, study authors say.